NYSE:INFU InfuSystem (INFU) Stock Price, News & Analysis $13.94 -0.20 (-1.41%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$13.94 0.00 (0.00%) As of 10/23/2026 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About InfuSystem Stock (NYSE:INFU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InfuSystem alerts:Sign Up Key Stats Today's Range$13.78▼$14.1150-Day Range$11.89▼$14.2352-Week Range$7.29▼$14.41Volume163,858 shsAverage Volume158,879 shsMarket Capitalization$281.34 millionP/E Ratio232.37Dividend YieldN/APrice Target$17.50Consensus RatingBuy Company Overview InfuSystem Holdings, Inc. is a health care services company that provides ambulatory infusion pump and related clinical support services. The company helps health care providers and patients manage therapies outside traditional hospital settings, with a particular focus on oncology and other treatments requiring portable infusion equipment. Its services include the rental and management of infusion pumps, equipment maintenance and biomedical services, delivery of related supplies, patient education, and 24-hour clinical and technical support. InfuSystem works with hospitals, clinics, physician practices, pharmaceutical manufacturers, insurers, and patients to support the administration of prescribed therapies. InfuSystem serves customers primarily in the United States and Canada. The company is headquartered in Rochester Hills, Michigan. Richard Diiorio serves as its president and chief executive officer.AI Generated. May Contain Errors. Read More InfuSystem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreINFU MarketRank™: 3.12877263581 of 5 starsInfuSystem scored higher than 63% of companies evaluated by MarketBeat, and ranked 309th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingInfuSystem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.Upside PotentialInfuSystem has a consensus price target of $17.50, representing about 25.5% upside from its current price of $13.94.Amount of Analyst CoverageInfuSystem has only been the subject of 1 research reports in the past 90 days.Read more about InfuSystem's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth106.67% Earnings GrowthEarnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 232.37, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.38.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 232.37, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.33.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 5.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for INFU. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest5 people have searched for INFU on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have not sold or bought any company stock.Percentage Held by Insiders10.80% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INFU Stock News HeadlinesContrasting Privia Health Group (NASDAQ:PRVA) and InfuSystem (NYSE:INFU)October 15, 2026 | americanbankingnews.comTranscript : InfuSystem Holdings, Inc. - Special CallSeptember 25, 2026 | marketscreener.comMA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.October 25 at 1:00 AM | Porter & Company (Ad)InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach TranscriptSeptember 24, 2026 | seekingalpha.comInfuSystem Holdings IncSeptember 22, 2026 | money.usnews.comInfuSystem to Host Investor Webcast on September 24, 2026September 17, 2026 | businesswire.comUnique Payer Network Strengthens InfuSystem (INFU)September 4, 2026 | finance.yahoo.comInfuSystem (INFU) Q2 2026 Earnings Call TranscriptAugust 11, 2026 | finance.yahoo.comSee More Headlines INFU Stock Analysis - Frequently Asked Questions How have INFU shares performed this year? InfuSystem's stock was trading at $8.97 at the beginning of 2026. Since then, INFU stock has increased by 55.4% and is now trading at $13.94. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSE:INFU) issued its quarterly earnings data on Thursday, November, 7th. The company reported $0.08 EPS for the quarter, hitting analysts' consensus estimates of $0.08. The company had revenue of $35.32 million for the quarter, compared to the consensus estimate of $35.50 million. InfuSystem had a net margin of 1.12% and a trailing twelve-month return on equity of 2.78%. Is InfuSystem buying back stock? InfuSystem's board authorized a stock buyback program on Tuesday, May 19th 2026, which permits the company to repurchase $20,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 10.3% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board of directors believes its shares are undervalued. Who are InfuSystem's major shareholders? InfuSystem's top institutional investors include GK Wealth Management LLC (0.03%). Insiders that own company stock include Richard Dilorio, Carrie Lachance, Barry G Steele, Scott Shuda, Paul Andrew Gendron, Addam Chupa, Ralph F Boyd Jr and Kenneth D Eichenbaum. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Marvell Technology (MRVL), Micron Technology (MU), Broadcom (AVGO), Palantir Technologies (PLTR) and Tesla (TSLA). Company Calendar Last Earnings11/07/2024Today10/25/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 INFU's financial health is in the Green zone, according to TradeSmith. INFU has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:INFU Previous SymbolNYSE:INFU CIK1337013 Webwww.infusystem.com Phone(248) 291-1210Fax800-455-4338Employees473Year Founded2005Price Target and Rating Average Price Target for InfuSystem$17.50 High Price Target$20.00 Low Price Target$15.00 Potential Upside/Downside+25.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.41 Trailing P/E Ratio232.37 Forward P/E Ratio92.93 P/E GrowthN/ANet Income$870 thousand Net Margins1.12% Pretax Margin2.65% Return on Equity2.78% Return on Assets1.41% Debt Debt-to-Equity Ratio0.50 Current Ratio1.98 Quick Ratio1.59 Sales & Book Value Annual Sales$143.34 million Price / Sales1.96 Cash Flow$1.09 per share Price / Cash Flow12.79 Book Value$2.47 per share Price / Book5.64Miscellaneous Outstanding Shares20,182,000Free Float19,095,000Market Cap$281.34 million OptionableOptionable Beta1.49 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NYSE:INFU) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
